Shanghai Yanghe Investment Management Co., Ltd. entered into an agreement to acquire 9.66% stake in Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHSE:603168) from Cheng Dekang for CNY approximately CNY 260 million on December 24, 2018. Under the terms of the transaction, Shanghai Yanghe Investment Management Co., Ltd. will acquire 31.2 million shares at CNY 8.33 per share. Out of total consideration, CNY 170 million will be paid within 3 working days from agreement date, CNY 70 million will be paid with 3 working days from Shanghai Stock Exchange issues the confirmation document for the transfer of the share agreement, and remaining within 3 working days from closing. Upon completion, Cheng Dekang will hold 93.5 million shares representing 28.97% stake. Shanghai Yanghe Investment Management Co., Ltd. completed the acquisition of 9.66% stake in Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHSE:603168) from Cheng Dekang on January 10, 2019.